Genetic predictors of fatigue in prostate cancer patients treated with androgen deprivation therapy: Preliminary findings

► Single nucleotide polymorphisms in interleukin-6 and tumor necrosis-alpha genes predict increases in fatigue in men initiating androgen deprivation therapy for prostate cancer.